Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026)
Takeda Pharmaceutical's EBT Margin came in at 13.34% for the quarter ended Jun 30, 2026, down 0.27 percentage points from 13.61% a year earlier and unchanged from the prior quarter.
Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported EBT Margin of 2.63%, down 4.33 percentage points year-over-year; for the year ended Mar 31, 2026, it was -3.16%, down 6.98 percentage points from the prior year.
- EBT Margin carries a five-year change of -14.61 percentage points (years ended Mar 2021 to Mar 2026).
- Going back by year, EBT Margin was 3.82% in the year ended Mar 31, 2025 (+2.58 pp), 1.24% in the year ended Mar 31, 2024 (-8.08 pp), 9.31% in the year ended Mar 31, 2023 (+0.84 pp) and 8.48% in the year ended Mar 31, 2022 (-2.97 pp).
- The five-year range for quarterly EBT Margin is -41.57% (the quarter ended Dec 31, 2025) to 22.93% (the quarter ended Mar 31, 2022).
- Year-over-year, EBT Margin increased in four of the last eight quarters, with an average year-over-year change of -5.42 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in the quarter ended Sep 30, 2023 (a gain of 3.74 percentage points), and the weakest in the quarter ended Dec 31, 2025 (a drop of 31.39 percentage points).
- Business Quant data shows TAK's EBT Margin at 13.34% (quarter ended Mar 31, 2026), -41.57% (quarter ended Dec 31, 2025) and 8.86% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 13.34% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.34% |
| Mar 31, 2026 | 13.34% |
| Dec 31, 2025 | -41.57% |
| Sep 30, 2025 | 8.86% |
| Jun 30, 2025 | 13.61% |
| Mar 31, 2025 | 12.47% |
| Dec 31, 2024 | -10.19% |
| Sep 30, 2024 | 8.00% |
| Jun 30, 2024 | 11.31% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | 4.56% |
| Sep 30, 2023 | 10.18% |
| Jun 30, 2023 | 12.76% |
| Mar 31, 2023 | 14.69% |
| Dec 31, 2022 | 9.77% |
| Sep 30, 2022 | 6.44% |
| Jun 30, 2022 | 15.99% |
| Mar 31, 2022 | 22.93% |
| Jun 30, 2021 | 23.48% |
| Mar 31, 2021 | 28.95% |
Takeda Pharmaceutical EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();